Involvement of PPAR nuclear receptors in tissue injury and wound repair

被引:181
作者
Michalik, L [1 ]
Wahli, W [1 ]
机构
[1] Univ Lausanne, Ctr Integrat Genom, Natl Res Ctr Frontiers Genet, CH-1015 Lausanne, Switzerland
关键词
D O I
10.1172/JCI27958
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tissue damage resulting from chemical, mechanical, and biological injury, or from interrupted blood flow and reperfusion, is often life threatening. The subsequent tissue response involves an intricate series of events including inflammation, oxidative stress, immune cell recruitment, and cell survival, proliferation, migration, and differentiation. In addition, fibrotic repair characterized by myofibroblast transdifferentiation and the deposition of ECM proteins is activated. Failure to initiate, maintain, or stop this repair program has dramatic consequences, such as cell death and associated tissue necrosis or carcinogenesis. In this sense, inflammation and oxidative stress, which are beneficial defense processes, can become harmful if they do not resolve in time. This repair program is largely based on rapid and specific changes in gene expression controlled by transcription factors that sense injury. PPARs are such factors and are activated by lipid mediators produced after wounding. Here we highlight advances in our understanding of PPAR action during tissue repair and discuss the potential for these nuclear receptors as therapeutic targets for tissue injury.
引用
收藏
页码:598 / 606
页数:9
相关论文
共 125 条
[1]   Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock [J].
Abdelrahman, M ;
Sivarajah, A ;
Thiemermann, C .
CARDIOVASCULAR RESEARCH, 2005, 65 (04) :772-781
[2]   The peroxisome proliferator-activated receptor-γ ligand 15-deoxyΔ12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock [J].
Abdelrahman, M ;
Collin, M ;
Thiemermann, C .
SHOCK, 2004, 22 (06) :555-561
[3]   Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null mice [J].
Anderson, SP ;
Yoon, L ;
Richard, EB ;
Duan, CS ;
Cattley, RC ;
Corton, JC .
HEPATOLOGY, 2002, 36 (03) :544-554
[4]   Cisplatin nephrotoxicity [J].
Arany, I ;
Safirstein, RL .
SEMINARS IN NEPHROLOGY, 2003, 23 (05) :460-464
[5]   Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer [J].
Barak, Y ;
Liao, D ;
He, WM ;
Ong, ES ;
Nelson, MC ;
Olefsky, JM ;
Boland, R ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :303-308
[6]   PPAR signaling in the control of cardiac energy metabolism [J].
Barger, PM ;
Kelly, DP .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) :238-245
[7]   Liver fibrosis [J].
Bataller, R ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218
[8]   Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? [J].
Baue, AE ;
Durham, R ;
Faist, E .
SHOCK, 1998, 10 (02) :79-89
[9]   Hypoxia up-regulates expression of peroxisome proliferator-activated receptor γ angiopoietin-related gene (PGAR) in cardiomyocytes:: Role of hypoxia inducible factor 1α [J].
Belanger, AJ ;
Lu, HW ;
Date, L ;
Liu, LX ;
Vincent, KA ;
Akita, GY ;
Cheng, SH ;
Gregory, RJ ;
Jiang, CW .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (07) :765-774
[10]  
BLOOMFIELD RH, 2001, CIRCULATION, V103, P2828